|Podcasts|September 20, 2022
The Oncologist: Patient Conversation Must Include Clinical Trials
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Dr. Shalaan Beg, VP of Oncology for Science 37, discusses his approach to reducing the time to trial activation at an NCI designated cancer center, how to ensure a diverse representation in clinical trials, and his opinion on decentralized and hybrid trials.
This podcast sponosored by
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
2
Operational Pragmatism in ePRO-heavy trials
3
How Selective Safety Data Collection Could Make Pragmatic Trials Scalable
4